Answers are grounded in this paper and cite their sources.
Lamivudine is a nucleoside reverse transcriptase inhibitor that is widely used for the treatment of HIV-1 infection in combination with other antiretrovirals. It is a highly effective agent that can be dosed once or twice daily due to its long intracellular half-life. It also has one of the best tolerability and long-term safety profiles among all antiretroviral agents and continues to be preferred as part of initial or subsequent combination therapy in HIV-infected patients.
No takes yet. Share an insight, caveat, or question.
Kumar et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: